Pacific Biosciences Of California reported $892.24M in Debt for its fiscal quarter ending in December of 2023.





Debt Change Date
Agilent USD 3.36B 1000K Mar/2026
Bruker USD 1.82B 153.5M Jun/2026
Danaher USD 26.48B 76M Sep/2026
General Electric Aerospace USD 19.33B 169M Sep/2026
Illumina USD 2.54B 9M Mar/2026
Myriad Genetics USD 59.3M 19.7M Mar/2025
Pacific Biosciences Of California USD 892.24M 653K Dec/2023
Quidel USD 3.08B 200.7M Jun/2026
Revvity USD 2.63B 707.45M Sep/2026
Roche Holding CHF 33.03B 1.41B Jun/2025
Standard Biotools USD 28.09M 1.4M Jun/2026
Thermo Fisher Scientific USD 42.55B 612M Jun/2026
Waters USD 5.45B 116M Jun/2026